PATENT CLAIM ANALYSIS

Application Number: 15934299
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["546", "133000"]

Abstract:
Provided herein are compounds and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with inhibition of HDAC (e.g., HDAC2).

Claim (Index 2):
A pharmaceutical composition comprising the compound of  claim 1 , or a pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.21429
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15741609', '15867982', '14417477', '15321410', '15786134']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7235135135998196
- 35 USC 102 Novelty (BERT): 0.5484449490187254
- Combined Prediction Score: 0.7060066571417103
- Mean Citation Score: 306.012022
- Max Citation Score: 398.32266
- Similarity Product: 345.0775752202069

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test